Concord Drugs standalone net profit rises 33.33% in the September 2020 quarter

Sales rise 17.60% to Rs 16.57 crore

Net profit of Concord Drugs rose 33.33% to Rs 0.08 crore in the quarter ended September 2020 as against Rs 0.06 crore during the previous quarter ended September 2019. Sales rose 17.60% to Rs 16.57 crore in the quarter ended September 2020 as against Rs 14.09 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales16.5714.09 18 OPM %5.376.32 -PBDT0.440.46 -4 PBT0.110.09 22 NP0.080.06 33

Powered by Capital Market - Live News